Carbapenems versus β-lactam and β-lactamase inhibitors for treatment of nosocomial pneumonia: A systematic review and meta-analysis

BACKGROUND: Carbapenems and β-lactam and β‐lactamase inhibitors (BLBLIs) have been used empirically in nosocomial pneumonia, but their efficacy and safety are controversial. OBJECTIVE: We carried out a systematic review with meta-analysis to evaluate the efficacy and safety of carbapenems versus BLB...

Descripción completa

Detalles Bibliográficos
Autores principales: Cang, Huai Qin, Quan, Xiang Hua, Chu, Xiang Hua, Liang, Yu, Yang, Xue, Li, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520732/
https://www.ncbi.nlm.nih.gov/pubmed/37767465
http://dx.doi.org/10.1016/j.heliyon.2023.e20108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520732/
https://www.ncbi.nlm.nih.gov/pubmed/37767465
http://dx.doi.org/10.1016/j.heliyon.2023.e20108

Ejemplares similares